 Recurrence rate discontinuation long-term mebendazole therapy alveolar echinococcosis preliminary results recurrence rate patients non-resectable alveolar echinococcosis discontinuation long-term therapy mebendazole average treatment years control group patients radical surgery course prophylactic postoperative mebendazole treatment years controls recurrence post-therapy period years contrast recurrence patients non-resectable alveolar echinococcosis average years discontinuation long-term mebendazole therapy absence detectable recurrence patients due spontaneous inactivation alveolar echinococcosis chemotherapy short post-therapy surveillance patients recurrence reintroduction chemotherapy data indicate mebendazole therapy parasitostatic parasiticidal